ATELLICA CH PHENCYCLIDINE (PCP) - COFEPRIS Registration 135R2018 SSA
Access comprehensive regulatory information for ATELLICA CH PHENCYCLIDINE (PCP) (ATELLICA CH PHENCYCLIDINE (PCP)) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 135R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS S DE RL DE CV. The device was registered on January 05, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ES PARA USO DIAGNOSTICO IN VITRO EN EL ANALISIS CUALITATIVO O SEMICUANTITATIVO DE FENCICLIDINA EN ORINA HUMANA. EL ENSAYO PCP SOLAMENTE BRINDA UN RESULTADO DE PRUEBA ANALITICA PRELIMINAR. AGENTE DE DIAGNOSTICO PARA USO EXCLUSIVO EN LABORATORIOS CLINICOS O
IT IS FOR IN VITRO DIAGNOSTIC USE IN THE QUALITATIVE OR SEMIQUANTITATIVE ANALYSIS OF PHENCYCLIDINE IN HUMAN URINE. THE PCP ASSAY PROVIDES ONLY A PRELIMINARY ANALYTICAL TEST RESULT. DIAGNOSTIC AGENT FOR USE IN CLINICAL LABORATORIES ONLY, OR